BELINDA STILLMAN: Open Payments
NPI 1497736144 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 37 payments from 9 companies in 2025. Trend: 2023 $1,853 · 2024 $1,203 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $156 |
| ABBVIE INC. | 4 | $72 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $63 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: UZEDY, VRAYLAR, INVEGA SUSTENNA, Qelbree, CAPLYTA, Auvelity, Jornay PM, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
